Phosphono-carboxylate compounds for treating amyloidosis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20040138178A1
SERIAL NO

10447310

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Therapeutic compounds and methods for modulating amyloid deposition in a subject, whatever its clinical setting, are described. Amyloid deposition is modulated by the administration to a subject of an effective amount of a therapeutic compound comprising a phosphonate group and a carboxylate group, a congener thereof, or a pharmaceutically acceptable salt or ester thereof. In preferred embodiments, an interaction between an amyloidogenic protein and a basement membrane constituent is modulated.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEUROCHEM (INTERNATIONAL) LIMITEDNEUHAUSSTRASSE 5 WALCHWIL CH-6318 SWITZERLAND

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gorine, Boris Edmonton, CA 7 47
Kong, Xianqi Pierrefonds, CA 84 724
Szarek, Walter A Kingston, CA 24 282
Thatcher, Gregory RJ Kingston, CA 14 59

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation